Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04302389 · ClinicalTrials.gov registry record · NA
Single Arm Trial of a Multi-component Commercial Digital Weight Loss Program
A NA study of Weight Loss, sponsored by University of Connecticut.
- Completed
- Registry status
- NA
- Development phase
- 153
- Enrollment target
- 1
- Study location
NCT04302389: Completed NA study of Weight Loss, sponsored by University of Connecticut.
NCT04302389 is a NA study of Weight Loss that has completed, run by University of Connecticut. The registered enrollment target is 153 participants, below the 1,500-participant average among 116 other Weight Loss trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04302389, a NA study of Weight Loss, has completed, sponsored by University of Connecticut.
- COMPLETED
- Registry status
- NA
- Development phase
- 153 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the proposed research project is to evaluate the acceptability and efficacy of an online multicomponent commercial weight loss program and to understand the relationship between program engagement and weight loss and health outcomes.
Primary Outcome
Percent of days participants used the diet tracking feature in the WW app during the intervention to track their daily food intake. A day of use will be defined as a day where participants tracked any food item in the WW app.
Conditions Studied
Interventions
- BEHAVIORAL myWW App, Virtual Workshops, and Private Facebook Group
Study Locations (1)
Connecticut
- University of Connecticut - Storrs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2021-02-10 |
| Est. Completion | 2021-11-01 |
| Phase | NA |
What the finished NCT04302389 record still lists
NCT04302389 is an interventional study that assigns participants to a tested intervention. The registered 153 participants enrollment target is mid-sized for trials with a published cap, below the 1,500-participant average among 116 other Weight Loss trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Weight Loss appearing as the primary indexed condition, and to 1 intervention - of which myWW App, Virtual Workshops, and Private Facebook Group is the first listed.
NCT04302389 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT04302389 about?
NCT04302389 is a clinical study titled "Single Arm Trial of a Multi-component Commercial Digital Weight Loss Program". The goal of the proposed research project is to evaluate the acceptability and efficacy of an online multicomponent commercial weight loss program and to understand the relationship between program engagement and weight loss and health outcomes.
What is the current status of trial NCT04302389?
This trial is currently completed. It is a NA study. The enrollment target is 153 participants. The study started on 2021-02-10. Estimated completion is 2021-11-01.
What conditions does trial NCT04302389 study?
This clinical trial studies the following conditions: Weight Loss.
What interventions are being tested in trial NCT04302389?
The interventions under investigation include: myWW App, Virtual Workshops, and Private Facebook Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT04302389?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04302389 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Weight Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04302389's enrollment target sits among peer trials
153 34th of 116 higher than 83 of 116 other Weight Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Weight Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Metabolic Health, Bones and Nuts During Weight Loss in Adults
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Exercise Effects on Adipose Tissue Structure and Function
RECRUITING · NA
-
Circadian Time Restricted Eating
RECRUITING · NA
-
Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05283265 · 153 participants · NA
Neurophysiological Mechanisms of Language Comprehension
- NCT05554393 · 153 participants · Phase 2
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
- NCT05584501 · 153 participants · NA
ETE Interventions in the Dental Setting
- NCT05714839 · 153 participants · Phase 1
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI